Feasibility Study of a Systematic Approach for Deprescribing of Statins and Proton Pump Inhibitors in Nursing Home Residents
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Polypharmacy
- Sponsor
- Zuyderland Medisch Centrum
- Enrollment
- 75
- Locations
- 1
- Primary Endpoint
- Decrease in pill burden (the dose of statins and PPI's)
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Deprescribing, the process of safely reducing or discontinuing unnecessary or harmful medication, has the potential to decrease polypharmacy and improve health outcomes. In this study a structured implicit algorithm, focusing on both extrinsic medication factors (eg change in disease) and intrinsic patient factors (eg. pill burden) will be used.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participant uses a statin and/or a proton pump inhibitor.
- •Participant signs informed consent.
- •Participant is a nursing home resident.
Exclusion Criteria
- •Participant is there for short term nursing home admission (\<3 months)
- •Participant is there for hospice admission.
Outcomes
Primary Outcomes
Decrease in pill burden (the dose of statins and PPI's)
Time Frame: 3 and 6 months after intervention.
On T0 (intervention) and on T1 + T2 (3 and 6 months after intervention), we will measure the dose of PPI's and statins on the medication list of every participant. These are provided by the pharmacist.
Decrease in pill burden (the number of statins and PPI's)
Time Frame: 3 and 6 months after intervention.
On T0 (intervention) and on T1 + T2 (3 and 6 months after intervention), we will measure the number of PPI's and statins on the medication list of every participant. These are provided by the pharmacist.
Secondary Outcomes
- Feasibility to use this algorithm.(3 and 6 months after intervention)
- All possible negative side effects of deprescribing (e.g. nausea, symptom recurrence)(From intervention to six months after intervention)